High-risk drugs such as antibodies need better safety checks, say experts.

Immunologists studying what went wrong in the fateful Northwick Park drug trial in London in March 2006 have developed a test that they say may have spotted the near-deadly effects of the ‘superantibody’ drug TGN1412.

Read more here